Circulating CD 40 ligand, Dickkopf‐1 and P‐selectin in HIV ‐infected patients
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Circulating
CD
40 ligand, Dickkopf‐1 and P‐selectin in
HIV
‐infected patients
Authors
Keywords
-
Journal
HIV MEDICINE
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2019-08-19
DOI
10.1111/hiv.12789
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cardiovascular markers of inflammation and serum lipid levels in HIV-infected patients with undetectable viremia
- (2018) Klaudija Višković et al. Scientific Reports
- Increased Risk of Myocardial Infarction in HIV-Infected Individuals in North America Compared With the General Population
- (2017) Daniel R. Drozd et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Time trend in hypertension prevalence, awareness, treatment, and control in a contemporary cohort of HIV-infected patients
- (2017) Giuseppe Vittorio De Socio et al. JOURNAL OF HYPERTENSION
- Predictive factors and prevalence of microalbuminuria in HIV-infected patients: a cross-sectional analysis
- (2017) Katia Falasca et al. BMC Nephrology
- Cardiovascular disease (CVD) and chronic kidney disease (CKD) event rates in HIV-positive persons at high predicted CVD and CKD risk: A prospective analysis of the D:A:D observational study
- (2017) Mark A. Boyd et al. PLOS MEDICINE
- Implications of American College of Cardiology/American Heart Association (ACC/AHA) Cholesterol Guidelines on Statin Underutilization for Prevention of Cardiovascular Disease in Diabetes Mellitus Among Several US Networks of Community Health Centers
- (2017) Ehimare Akhabue et al. Journal of the American Heart Association
- Hypertension Is a Key Feature of the Metabolic Syndrome in Subjects Aging with HIV
- (2016) Raquel Martin-Iguacel et al. CURRENT HYPERTENSION REPORTS
- 2016 European Guidelines on cardiovascular disease prevention in clinical practice
- (2016) Massimo F. Piepoli et al. EUROPEAN HEART JOURNAL
- The effect of HAART-induced HIV suppression on circulating markers of inflammation and immune activation
- (2015) Nikolas Itaru Wada et al. AIDS
- Long term effect of telmisartan in HIV-positive male patients with high blood pressure
- (2015) Claudio Ucciferri et al. Brazilian Journal of Infectious Diseases
- Effect of Probiotic Supplement on Cytokine Levels in HIV-Infected Individuals: A Preliminary Study
- (2015) Katia Falasca et al. Nutrients
- Increased risk of cardiovascular disease (CVD) with age in HIV-positive men: a comparison of the D:A:D CVD risk equation and general population CVD risk equations
- (2014) K Petoumenos et al. HIV MEDICINE
- The value of flow cytometry in the measurement of platelet activation and aggregation in human immunodeficiency virus infection
- (2014) Bongani B. Nkambule et al. PLATELETS
- Circulating Myeloid‐Related Protein–8/14 is Related to Thromboxane‐Dependent Platelet Activation in Patients With Acute Coronary Syndrome, With and Without Ongoing Low‐Dose Aspirin Treatment
- (2014) Francesca Santilli et al. Journal of the American Heart Association
- Circulating Dickkopf‐1 in Diabetes Mellitus: Association With Platelet Activation and Effects of Improved Metabolic Control and Low‐Dose Aspirin
- (2014) Stefano Lattanzio et al. Journal of the American Heart Association
- Prehypertension, Hypertension, and the Risk of Acute Myocardial Infarction in HIV-Infected and -Uninfected Veterans
- (2013) Kaku A. Armah et al. CLINICAL INFECTIOUS DISEASES
- Effect of antiviral therapy on pro-angiogenic hematopoietic and endothelial progenitor cells in HIV-infected people
- (2013) Jacopo Vecchiet et al. THROMBOSIS RESEARCH
- HIV Infection and the Risk of Acute Myocardial Infarction
- (2013) Matthew S. Freiberg et al. JAMA Internal Medicine
- Short Communication: Proangiogenic Hematopoietic Cells In Acute HIV Infection
- (2012) Katia Falasca et al. AIDS RESEARCH AND HUMAN RETROVIRUSES
- Relative risk of cardiovascular disease among people living with HIV: a systematic review and meta-analysis
- (2012) FM Islam et al. HIV MEDICINE
- Detection of circulating platelet–monocyte complexes in persons infected with human immunodeficiency virus type-1
- (2012) Meera V. Singh et al. JOURNAL OF VIROLOGICAL METHODS
- Antihypertensive and metabolic effects of telmisartan in hypertensive HIV-positive patients
- (2011) Jacopo Vecchiet et al. ANTIVIRAL THERAPY
- Cardiovascular implications from untreated human immunodeficiency virus infection
- (2011) J. V. Baker et al. EUROPEAN HEART JOURNAL
- Increased Platelet and Microparticle Activation in HIV Infection
- (2011) Elizabeth Mayne et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Endothelial and platelet function alterations in HIV-infected patients
- (2011) P. Gresele et al. THROMBOSIS RESEARCH
- Endothelial progenitor cell trafficking in human immunodeficiency virus-infected persons
- (2010) Luciana Teofili et al. AIDS
- Causes of Death in HIV‐1–Infected Patients Treated with Antiretroviral Therapy, 1996–2006: Collaborative Analysis of 13 HIV Cohort Studies
- (2010) CLINICAL INFECTIOUS DISEASES
- Cystatin C, Adipokines and Cardiovascular Risk in HIV Infected Patients
- (2010) Katia Falasca et al. CURRENT HIV RESEARCH
- Changes in Causes of Death Among Adults Infected by HIV Between 2000 and 2005: The “Mortalité 2000 and 2005” Surveys (ANRS EN19 and Mortavic)
- (2009) Charlotte Lewden et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Soluble CD40L in Mediterranean Spotted Fever: Relation to oxidative stress and platelet activation
- (2009) Stefano Lattanzio et al. THROMBOSIS RESEARCH
- Wnt5A/CaMKII Signaling Contributes to the Inflammatory Response of Macrophages and Is a Target for the Antiinflammatory Action of Activated Protein C and Interleukin-10
- (2008) Claudia Pereira et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Association of low-grade inflammation and platelet activation in patients with hypertension with microalbuminuria
- (2008) Patrizia Ferroni et al. CLINICAL SCIENCE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started